TRIESENCE, 8mg/2.0mL, Injectable, 0.2 mL plastic syringe, RX, Creative Compounds, Wilsonville, OR 97070
Recall Number: D-0226-2015
Firm: Oregon Compounding Centers, Inc. dba Creative Compounds
Classification: Class II
Status: Terminated
Report Date: 20141112
Initiation Date: 20141006
Termination Date: 20150630
Reason for Recall
Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Product Description
TRIESENCE, 8mg/2.0mL, Injectable, 0.2 mL plastic syringe, RX, Creative Compounds, Wilsonville, OR 97070